Agilent (A) to Bolster DCG Segment With Upcoming Solutions

Agilent Technologies (A) has announced its plans to introduce new cell analysis, genomics, digital pathology and companion diagnostics solutions to highlight its advancement in cancer research and diagnostics at the American Association for Cancer Research Annual Meeting.This includes Agilent NovoCyte Opteon Spectral Flow Cytometer, a user-friendly, advanced spectral flow cytometry system with multiple marker panels and up to 70 detectors, enhancing cancer research capabilities.Further, the company will als ...